Epidemiology of HTLV-I infection in Spain

International Journal of Epidemiology

Volumn 25, Issue 2, 1996, Pages 443-448

  Soriano, Vicenç ^a   Gutiérrez, Maite ^a   Vallejo, Alejandro ^a   Aguilera, Antonio ^a   Pujol, Emilio ^a   Calderón, Enrique ^a   González Lahoz, Juan ^a  

^a NONE   (Spain)

Author keywords

Epidemiology; HIV 1; HTLV I; PCR; Spain

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ARTHROPATHY; ARTICLE; BLOOD DONOR; CENTRAL AMERICA; CLINICAL ARTICLE; FEMALE; GRANULOMATOSIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMIGRANT; JAPAN; LUNG ALVEOLITIS; MALE; MELANESIA; MIDDLE EAST; PRIORITY JOURNAL; SEXUALITY; SKIN INFLAMMATION; SOUTH AMERICA; SPAIN; SPASTIC PARAPLEGIA; T CELL LYMPHOMA; UVEITIS;

ADOLESCENT; ADULT; AGED; BLOOD BANKS; CHILD; EMIGRATION AND IMMIGRATION; FEMALE; HTLV-I INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; RESIDENCE CHARACTERISTICS; SEX DISTRIBUTION; SPAIN;

EID: 0029871702     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/25.2.443     Document Type: Article

References (56)

1. Poiesz B, Ruscetti F, Gazdar A, Bunn D, Minna J, Gallo R. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980, 77: 415-19.
2. Miyosi I, Kubonishi I, Yoshimoto S Type C virus particles in a cord Y-cell line derived by cocultivating normal human leukocytes and human leukemic cells. Nature 1981, 294: 770-71.
3. Gessain A, Barin F, Vernant J. Antibodies to HTLV-I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407-10.
4. Blattner W A. Epidemiology of HTLV-I and associated diseases. In Blattner W A (ed.). Human Retrovirology: HTLV. New York: Raven Press, 1990, pp. 251-65.
5. Kaplan J, Osame M, Kubota H et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J AIDS 1990; 3: 96-101.
6. Kamihira S, Nakasima S, Oyakawa Y et al. Transmission of HTLV-I by blood transfusion before and after mass-screening of sera from seropositive donors. Vox Sang 1987; 52: 43-44.
7. CDC. Licensure of screening tests for antibody to HTLV-I. MMWR 1988; 37: 736-47
8. Couroucé A, Pillonel J, Lemaire J M, Maniez M, Brunet J B. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. AIDS 1993; 7: 841-47.
9. Soriano V, Calderon E HTLV-I and transfusions. Med Clin (Barc) 1993; 100: 177-78.
10. Estébanez P, Varela J, Rúa-Figueroa M et al. The presence of HTLV-I/II in non-intravenous drug using Spanish prostitutes. Int J Sex Trans Dis & AIDS 1992; 3: 62-63.
11. e. Leucemia/linfoma de células T del adulto en España. Descripción de un caso con fenotipo OKT4+; OKT8- y actividad funcional cooperadora. Med Clin (Barc) 1986; 86: 469-71.
12. Montserrat E, Lozano M, Urbano-Ispizua A et al. Adult T-cell leukemia in a Chilean resident in Spain. long-lasting remission after 2-deoxycoformycin treatment. Leuk Lymph 1989; 1: 47-49.
13. Soriano V, Tor J, Ribera A et al. HIV-1, HIV-2 and HTLV-I in high-risk groups in Spain. AIDS 1989; 3: 615-16.
14. Soriano V, Tor J, Monzón M, Graus F, Clotet B, Ribas-Mundó M HTLV-I in Spain. Lancet 1990; 326: 627-28.
15. Alvarez R, Pujol A, Graus F, Soriano V, Corachán M, Tolosa E. Paraparesia espsática tropical y HTLV-I. Primer caso en España. Med Clin (Barc) 1991; 96: 258-60.
16. Pujol E, Ollero M, Márquez P, Gimeno A. Infección por HTLV-I en un colectivo con prácticas de riesgo. Med Clin (Barc) 1990; 94: 477.
17. Pujol E, Ollero M, Máquez P, Gea A, Alcoucer R, Gimeno A. Infección por HTLV-I en marineros que viajan al Africa occidental subsahariana. Enf Infecc Microbiol Clin 1991; 9: 283-85
18. Estébanez P, Sarasqueta C, Nájera R et al. Prevalence of HIV-1, HIV-2, and HTLV-I/II in Spanish seamen. J AIDS 1992; 5: 316-17.
19. Castillo M, Sánchez J, Varela J et al. Granulomatosis linfomatoidea: análisis clínico-patológico de 7 casos. Med Clin (Barc) 1992; 98: 540-42.
20. Prieto J, Lema M, Castillo J, Noya M. Paraparesia espástica tropical e infección por HTLV-I en España. Neurologia 1992; 7: 237-38.
21. Soriano V, Calderón E, Esparza B et al HTLV-I/II infections in Spain. Int J Epidemiol 1993, 22: 716-19.
22. Soriano V, Calderón E, Cilla G et al. Análisis multicéntrico de la infección por HTLV-I y HTLV-II en España. Med Clin (Barc) 1993; 100: 492-96.
23. Soriano V, Gutirérez M The HIV-2 Med Clin (Barc) 1994; 102: 387-94.
24. Soriano V, Tor J, Ribera A, Flores A, Casals A, Ribas-Mundó M. Investigación del HTLV-I en pacientes de Barcelona con conectivopatías, enfermedades neurológicas desmielinizantes y síndromes linfoproliferativos. Med Clin (Barc) 1990, 94: 730-32.
25. Cilla G, Iturriza M, Peris A, Ṕrez-Trallero E. Bajo riesgo de infección por HTLV-I en España. Med Clin (Barc) 1990; 94: 476-77.
26. Esparza B, Olabarría I, García M, Miguel F. Ausencia de infección por el retrovirus HTLV-I en síndromes linfoproliferativos en la provincia de Vizcaya. Med Clin (Barc) 1990; 94: 757-58.
27. Soriano V, Ordi J, Grau J. Tests for HIV in lupus. N Engl J Med 1994; 331: 881.
28. Agius G, Vaillant V, Biggar R et al. Absence of antibodies to HTLV-I/II in French patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1988; 7: 815-16.
29. Dolken G, Bross K, Chosa Z No evidence for HTLV infection among leukemia patients in Germany. Lancet 1983; i: 1495.
30. Blomberg J, Faldt R Antibodies to HTLV-I associated antigen in Swedish leukemia patients and blood donors. Br J Haematol 1985; 60: 555-57.
31. Soriano V, Calderón E, Gutiérrez M, Martínez-Zapico R, González-Lahoz J. Misdiagnosis of HTLV-II infection using HTLV-I viral lysate screening assays. AIDS 1993; 7: 1395.
32. Coste J, Lemaire J M, Couroucé A M. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. AIDS 1993; 7: 440-41.
33. Lee H, Weiss S, Brown L et al. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the Middle Atlantic and Central Regions of the USA. J Infect Dis 1990; 162: 347-53.
34. Zella D, Cavicchini A, Salemi M, Bertazzoni U. Molecular characterization of two isolates of HTLV-II from Italian drug abusers and comparison of genome structure with other isolates. J Gen Virol 1993; 74: 437-44.
35. Henrard D, Soriano V, Robertson E et al. Prevalence of HTLV-I and HTLV-II infection among Spanish drug users measured by HTLV-I assay and HTLV-I and -II assay. J Clin Microbiol 1995; 33: 735-38.
36. Mayer V, Ebbesen P. HTLV-I virus in Europeans: the continuous spread. A meta-analysis. Acta Virol 1991; 35: 472-95.
37. Soriano V, Pillonel J, Wicks R et al. HTLV-I and HTLV-II in Western Europe. J Clin Microbiol (In press), 1995
38. Cardosa E, Robert-Guroff M, Franchini G et al. Seroprevalence of HTLV-1 in Portugal and evidence of double retrovirus infection in a healthy donor. Int J Cancer 1989; 43: 195-200.
39. Esparza B, Robert-Guroff M, Blattner W A, Merino F. Frecuencia de anticuerpos naturales al virus de la leucemia/linfoma de células T del adulto subgrupo I (HTLV-I) en donantes de bancos de sangre de España. Inmunología 1986; 5: 90-99.
40. Constantine N, Fox E, Need to confirm HTLV-I screening assays. Lancet 1989, i: 108-09.
41. De Stasio G, Canavaggio M, Rizzi L et al. Screening for anti-HTLV antibody in blood donors and polytransfused patients in Apulia (Italy). Vox Sang 1990; 59: 167-71.
42. Lee H, Swanson P, Rosenblatt J et al Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337: 435-38.
43. Williams A, Fang C, Slamon D et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988; 240: 643-46.
44. Fang C, Akius R, Sandler S et al. HTLV-I antibodies in blood donors. Transfusion 1989; 29 (Suppl. 1): 38.
45. Brennan M, Runganga J, Barbara J et al. Prevalence of antibodies to Human T cell leukemia/lymphoma virus I blood donors in North London. Br Med J 1993; 307: 235-39.
46. Kamihira S, Sohda H, Oyakawa N et al. Immunoglobulin classes of antibody for HTLV-I in healthy donor and HTLV-I associated disorders. Vox Sang 1989; 56: 168-73.
47. Achiron A, Pinhas-Hamiel O, Doll L et al. Spastic paraparesis associated with HTLV type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Ann Neurol 1993; 34: 670-75.
48. Srivastava B, Gonzales C, Loftus R, Fitzpatrick J, Saxinger C Examination of HTLV-I ELISA-positive leukemia/ lymphoma patients by Western blotting gave mostly negative or indeterminate reaction. AIDS Res Hum Retroviruses 1990; 6: 617-27.
49. De Andrés R, Pérez-Alvárez L, Nájera R. HIV seropositivity of blood donations in Spain: a 4-year surveillance (1988-1991). AIDS 1993; 7: 283-84.
50. Phillips A, Sabin C, Elford J, Bofill M, Janossy G, Lee C. Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection. Br Med J 1994; 309: 309-13.
51. Tajima K, Kuorishi T. Estimation on rate of incidence of ATL among HTLV-I carriers in Kiushu, Japan. Jpn J Clin Oncol 1985; 15: 423-30.
52. Okochi K, Sato H, Hinuma Y et al. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984; 46: 245-53.
53. Gout O, Baulac M, Gessain A. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 1990; 322: 383-88
54. Osame A, Izumo S, Igata A, Matsumoto M, Matsumoto T, Sonoda S. Blood transfusion and HTLV-I associated myelopathy. Lancer 1983; ii: 104-05.
55. McAlpine L, Parry J, Tosswill J et al. Evaluation of an EIA for the combined detection of antibodies to HIV-1, HIV-2, HTLV-I and HTLV-II. AIDS 1992; 6: 387-91.
56. Vallejo A, Gutiérrez M, Soriano V. HTLV-I/II infection among immigrants to Spain. Vox Sang 1994; 67: 79-80.